GNPX Genprex, Inc.
Healthcare$0.77-5.98%ClosedMarket Cap: $1.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.34
P/S
0.00
EV/EBITDA
1.04
DCF Value
$7.64
FCF Yield
-1066.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-247.3%
ROA
-82.4%
ROIC
-94.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-4.5M | $-4.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.5M | $-3.8M | $— | — |
| FY null | $0.00 | NaN% | $-15.5M | $-16.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.3M | $-3.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-4.7M | $-4.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.0M | $-4.0M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-4.3M | $-4.3M | $— | — |
| FY null | $0.00 | -Infinity% | $-21.2M | $-21.1M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-4.3M | $-4.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-6.5M | $-6.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-6.0M | $-6.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-6.0M | $-5.9M | $-199.50 | — |